Healthcare's Bio/Pharma-Fueled Bull Continues; But
its advance has effectively stalled just above it's Deep Crab PRZ, and at a confluence of APF and structured resistance. Reflecting the ebb in momentum, XLV's rate-of-change is at its lowest since December 2012.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。